欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号AT/H/0563/001
药品名称Linezolid Pharmathen 2 mg/ml solution for infusion
活性成分
    • linezolid 2.0 mg/ml
剂型Solution for infusion
上市许可持有人Pharmathen S.A Dervenakion str., Pallini, Attiki 153 51 Greece
参考成员国 - 产品名称Austria (AT)
Linezolid Pharmathen 2 mg/ml Infusionslösung
互认成员国 - 产品名称
    • United Kingdom (Northern Ireland) (XI)
    • France (FR)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
      LIZEDIA
    • Cyprus (CY)
许可日期2015/11/11
最近更新日期2021/11/10
药物ATC编码
    • J01XX08 linezolid
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase